Showing results (501-510 of 857) with videos related to
Sort By:
Pageof 86
Cancers|March 1, 2019
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver MutationsSusumu Iiizumi, Junya Ohtake, Naoko Murakami, et al.Acta Medica Okayama|December 24, 2024
Treatment of Tenosynovial Giant Cell Tumor of the Cervical Spine with Postoperative Anti-RANKL Antibody (Denosumab) AdministrationYuichi Hirata, Takayuki Nagase, Susumu Sasada, et al.Biochemical and Biophysical Research Communications|August 31, 1990
Production, purification and characterization of biologically active recombinant human nerve growth factorM Iwane, Y Kitamura, Y Kaisho, et al.Leukemia Research|April 16, 2018
Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndromeKeiko Sasada, Noriko Yamamoto, Hiroki Masuda, et al.Chemical Science|June 14, 2021
Efficient light-harvesting, energy migration, and charge transfer by nanographene-based nonfullerene small-molecule acceptors exhibiting unusually long excited-state lifetime in the film stateTomokazu Umeyama, Kensho Igarashi, Daiki Sasada, et al.International Journal of Hematology|August 7, 2007
Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failureKazunari Sasaki, Kouhei Yamashita, Takashi Miyoshi, et al.Journal of Medical Virology|July 17, 2024
Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B PatientsTakanori Suzuki, Kentaro Matsuura, Takako Inoue, et al.Lung Cancer (Amsterdam, Netherlands)|September 6, 2015
Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinomaShuji Murakami, Hiroyuki Ito, Norifumi Tsubokawa, et al.International Journal of Surgery Case Reports|July 22, 2017
Complete torsion of gallbladder following laparoscopic cholecystectomy: A case studyTomoaki Bekki, Tomoyuki Abe, Hironobu Amano, et al.Cancer Science|June 17, 2017
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapiesShigeru Yutani, Takahisa Shirahama, Daisuke Muroya, et al.Pageof 86